Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study

Rakesh S. Birjmohun, Menno Vergeer, Erik S. G. Stroes et al. · 2009

Read Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study by Rakesh S. Birjmohun, Menno Vergeer, Erik S. G. Stroes et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006809.txt.

Description

Rakesh S. Birjmohun and colleagues tested whether an HDL enzyme predicts heart disease in PLOS ONE in 2009. The enzyme is paraoxonase-1, an antioxidant riding on HDL particles. A common variant, Q192R, strongly influences its activity. The enzyme was thought to protect against atherosclerosis. Whether that protection is independent was unclear.

The EPIC-Norfolk prospective study followed a general population over time. Neither genotype nor enzyme activity predicted future coronary artery disease. The title reports that null result directly. Null results matter because they prune false leads in prevention research. This one argues against using paraoxonase-1 as a risk marker.

Catalog record

CREATORRakesh S. Birjmohun, Menno Vergeer, Erik S. G. Stroes et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006809

Browse the full library · About the Tower of Babel